Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: lh56 who wrote (46249)	4/3/2002 11:36:43 AM
From: Zeev Hed	Read Replies (3) \| Respond to of 99280

The momentum players are deserting, the next stop could be $35. It won't go there straight line, so I added here at $36.80, hoping for an interim bounce (it is a discount of better than $2 to my last sale, after all. (g).. I took already two losses on the lunch deployment, GNSS at $24 ($.30) and JNPR at $12 ($.13). Zeev

To: lh56 who wrote (46249)	4/3/2002 11:38:23 AM
From: lh56	Read Replies (1) \| Respond to of 99280

"03-Apr-02 Tenet Healthcare (THC) 67.37 -0.88: Yesterday, company posted Q3 EPS $0.04 above consensus and in line revs. Also, raised Q4 guidance to at least $0.90 vs consensus of $0.87. The stock rose on this news, but despite the positive announcement, THC is trading slightly lower today (-1.3%)... Fulcrum reiterated Buy rating and price target of $92.75; also raised estimates for Q4 and FY02 to $0.91 (vs. $0.88) and $3.21 (vs. $3.15), respectively. Firm thinks continued growth of 25% or better is likely, and views THC as the only really undervalued hospital company." wasn't there some commentary on this 'Fulcrum' outfit? anybody know anything about these guys? THC has been a solid performer for me since the mid $30's. larry